ArticleMolecules (Basel, Switzerland)2026
Structural Elucidation of Azo and Quinoneimine Products Formed in Diazonium-Based Color Reactions of Cannabinoids.
Hikari Nishiguchi, Kayo Nakamura, Ryosuke Arai, Riho Hamajima, Hiroko Abe, Akihiko Ishida, Manabu Tokeshi, Kyohei Higashi, Akiyoshi Saitoh, Hideyo Takahashi
Abstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Hikari NishiguchiFaculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo 125-8585, Japan.
Kayo NakamuraFaculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo 125-8585, Japan.ORCID 0000-0003-4577-060X Ryosuke AraiFaculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo 125-8585, Japan.
Riho HamajimaFaculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo 125-8585, Japan.
Hiroko AbeBioDesign Inc., IB Daiichi-Bld 6th Floor, 3-25-15 Nishi-Ikebukuro, Toshima-ku, Tokyo 171-0021, Japan.
Akihiko IshidaFaculty of Engineering, Hokkaido University, Kita 13, Nishi 8, Kita-ku, Sapporo 060-8628, Japan.ORCID 0000-0003-4100-9426 Manabu TokeshiFaculty of Engineering, Hokkaido University, Kita 13, Nishi 8, Kita-ku, Sapporo 060-8628, Japan.ORCID 0000-0002-4412-2144 Kyohei HigashiFaculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo 125-8585, Japan.ORCID 0000-0002-2622-4825 Akiyoshi SaitohFaculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo 125-8585, Japan.
Hideyo TakahashiFaculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo 125-8585, Japan.ORCID 0000-0001-5965-3987 Funding
Japan Science and Technology Agency A-STEP (JPMJTR224B)
6 · The paper itselfAbstract
Cannabis use is generally restricted worldwide because it contains the narcotic compound Δ
Indexed as
Azo CompoundsCannabinoidsDiazonium CompoundsColorMolecular StructureAzo CompoundsCannabinoidsDiazonium Compoundscannabichromenecannabidiolcannabigerolcannabinoidcannabinolcannabiscolor reactiondiazo couplinghexahydrocannabinolΔ9-tetrahydrocannabinol
Identifiers
PMID41828784
PMCPMC12986091
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390